LPL Financial
GNMX

LPL Financial’s Aevi Genomic Medicine Inc GNMX Stock Holding History

LPL Financial’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,696
Closed -$20K – 3040
2017
Q1 		$20K Sell
11,696
-27,430
-70% -$124K ﹤0.01% 2681
2016
Q4 		$213K Sell
39,126
-1,477
-4% -$7.77K ﹤0.01% 2441
2016
Q3 		$223K Sell
40,603
-2,507
-6% -$14.3K ﹤0.01% 2339
2016
Q2 		$247K Sell
43,110
-45,458
-51% -$239K ﹤0.01% 2230
2016
Q1 		$429K Sell
88,568
-1,700
-2% -$7K ﹤0.01% 2256
2015
Q4 		$538K Buy
90,268
+43,211
+92% +$293K ﹤0.01% 2141
2015
Q3 		$328K Buy
47,057
+110
+0.2% +$853 ﹤0.01% 2135
2015
Q2 		$298K Sell
46,947
-750
-2% -$5.81K ﹤0.01% 2308
2015
Q1 		$386K Sell
47,697
-550
-1% -$4.15K ﹤0.01% 2042
2014
Q4 		$244K Sell
48,247
-3,021
-6% -$14.9K ﹤0.01% 2341
2014
Q3 		$247K Sell
51,268
-1,091
-2% -$7.04K ﹤0.01% 2313
2014
Q2 		$407K Buy
52,359
+840
+2% +$5.93K ﹤0.01% 1961
2014
Q1 		$360K Sell
51,519
-3,685
-7% -$28.8K ﹤0.01% 2011
2013
Q4 		$331K Sell
55,204
-11,982
-18% -$78.4K ﹤0.01% 2045
2013
Q3 		$427K Hold
67,186
– – ﹤0.01% 1759
2013
Q2 		$255K Buy
+67,186
New +$275K ﹤0.01% 2019

Other funds holding GNMX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

LPL Financial's GNMX Position: Q2 2017 in Review

LPL Financial sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2017, closing a stake of 11,696 shares — an estimated $20K sold.

LPL Financial first reported a position in GNMX in Q2 2013 and held it in 16 quarters. The position peaked at $538K in Q4 2015. 51 funds tracked by Wall St. Rank hold GNMX as of Q2 2017.

  • LPL Financial reported no remaining Aevi Genomic Medicine Inc position as of Q2 2017 after selling out during the quarter.
  • LPL Financial sold 11,696 Aevi Genomic Medicine Inc shares in Q2 2017, an estimated $20K.
  • LPL Financial first reported a position in Aevi Genomic Medicine Inc in Q2 2013 and held it in 16 quarters.
  • LPL Financial's Aevi Genomic Medicine Inc position peaked at $538K in Q4 2015.
  • 51 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2017.

Based on LPL Financial's 13F filing for Q2 2017, filed 14 Aug 2017.